Stephanie Lovell

Executive Vice President, Medicare, and Chief Legal Officer,
Blue Cross Blue Shield of MA

Stephanie is executive vice president, Medicare, and chief legal officer for Blue Cross Blue Shield of Massachusetts, the largest private health plan in Massachusetts and one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country. The company serves nearly 3 million members and is rated among the nation’s best health plans for overall member satisfaction and quality.

She has overall responsibility for the strategic growth and performance of Blue Cross’ Medicare program representing over 375,000 members and $ 1.5 billion in revenue. She also leads the company’s law department and government and regulatory affairs function and provides strategic counsel to help ensure the company continues to meet key corporate goals – including making quality health care affordable for individuals, families and employers.

Stephanie has extensive experience in both the public and private sectors. She joined Blue Cross in December 2011 after more than four years at Boston Medical Center (BMC), where she served as senior vice president of administration and general counsel. At BMC, Lovell was responsible for legal affairs, strategic planning, compliance, human resources, and facilities. Prior to BMC, she served in the Office of the Attorney General for more than six years, including three years as first assistant attorney general and three years as the government bureau chief.

Earlier in her career, Stephanie served as the executive director of the state ethics commission, and prior to that as assistant general counsel for litigation for the Boston School Committee. Her private sector experience includes serving as senior litigation associate at the former Fitch, Wiley, Richlin & Tourse, and the former Hill & Barlow.

Stephanie currently serves on the investment committee of the Goodwill Industries of Massachusetts and is a member of the board of directors for The Partnership, Inc., chairing the board’s audit committee. She is a member of the board of directors and serves on the audit committee of Cyclerion Therapeutics, a publicly traded bio pharmaceutical company located in Cambridge, Massachusetts.

She holds a Juris Doctorate from Boston University School of Law and a bachelor’s degree in philosophy from Hamilton College.